BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.71B |
| 2 |
Alibaba
BABA
|
+$2.19B |
| 3 |
Truist Financial
TFC
|
+$2.16B |
| 4 |
iShares MBS ETF
MBB
|
+$841M |
| 5 |
ServiceNow
NOW
|
+$829M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$5.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$2.34B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$983M |
| 4 |
VIAB
Viacom Inc. Class B
VIAB
|
+$684M |
| 5 |
Apple
AAPL
|
+$623M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Financials | 14.42% |
| 3 | Healthcare | 13.59% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Goldman Sachs BDC
GSBD
$1.1B
| $4.77M | ﹤0.01% |
224,298
+7,329
| +3% | +$151K |
|
3502
Crawford & Co Class B
CRD.B
$604M
| $4.75M | ﹤0.01% |
468,022
+129
| +0% | +$1.27K |
|
|
MTL
3503
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
| $4.75M | ﹤0.01% |
2,305,440
+135,949
| +6% | +$255K |
|
3504
Telefônica Brasil
VIV
$19.2B
| $4.75M | ﹤0.01% |
331,527
+224,428
| +210% | +$3M |
|
3505
PUT
GE Aerospace
GE
$384B
| $4.73M | ﹤0.01% |
85,070
+31,099
| +58% | +$1.61M |
|
3506
Bain Capital Specialty
BCSF
$850M
| $4.71M | ﹤0.01% |
242,913
+7,943
| +3% | +$149K |
|
|
EVFM
3507
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $4.71M | ﹤0.01% |
50,886
+102
| +0.2% | +$8.61K |
|
|
INDT
3508
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
| $4.7M | ﹤0.01% |
118,770
+25
| +0% | +$972 |
|
3509
Cibus
CBUS
$138M
| $4.67M | ﹤0.01% |
13,327
+524
| +4% | +$132K |
|
3510
iShares MSCI Intl Momentum Factor ETF
IMTM
$4.27B
| $4.65M | ﹤0.01% |
149,199
-48,201
| -24% | -$1.45M |
|
3511
Matinas BioPharma
MTNB
$1.81M
| $4.65M | ﹤0.01% |
40,978
+27,852
| +212% | +$1.61M |
|
3512
Texas Pacific Land
TPL
$23.5B
| $4.64M | ﹤0.01% |
53,523
-549
| -1% | -$40.1K |
|
3513
Information Services Group
III
$251M
| $4.63M | ﹤0.01% |
1,829,290
+20,579
| +1% | +$48.9K |
|
|
BPMP
3514
DELISTED
BP Midstream Partners LP Common Units representing Limited Partner Interests
BPMP
| $4.62M | ﹤0.01% |
296,112
-39,565
| -12% | -$587K |
|
3515
ProQR Therapeutics
PRQR
$265M
| $4.61M | ﹤0.01% |
465,562
-332,566
| -42% | -$2.59M |
|
|
IVAC
3516
DELISTED
Intevac Inc
IVAC
| $4.61M | ﹤0.01% |
652,604
-374
| -0.1% | -$2.19K |
|
3517
Greene County Bancorp
GCBC
$589M
| $4.57M | ﹤0.01% |
317,702
+2,560
| +0.8% | +$35.8K |
|
|
SOLY
3518
DELISTED
Soliton, Inc.
SOLY
| $4.53M | ﹤0.01% |
413,061
+61,567
| +18% | +$705K |
|
|
MORF
3519
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $4.53M | ﹤0.01% |
264,178
-1,082
| -0.4% | -$16.9K |
|
3520
Lee Enterprises
LEE
$182M
| $4.5M | ﹤0.01% |
317,091
-141
| -0% | -$2.52K |
|
3521
Travelzoo
TZOO
$75.4M
| $4.5M | ﹤0.01% |
420,817
-562
| -0.1% | -$5.83K |
|
|
UROV
3522
DELISTED
Urovant Sciences Ltd.
UROV
| $4.5M | ﹤0.01% |
290,270
+4,730
| +2% | +$51.3K |
|
3523
Safe Bulkers
SB
$774M
| $4.49M | ﹤0.01% |
2,638,238
-61,424
| -2% | -$107K |
|
|
PCTI
3524
DELISTED
PCTEL, Inc. Common Stock
PCTI
| $4.47M | ﹤0.01% |
527,821
-18,632
| -3% | -$155K |
|
3525
Carlyle Secured Lending
CGBD
$758M
| $4.45M | ﹤0.01% |
332,577
+4,031
| +1% | +$55.8K |
|
Similar funds
BlackRock's Q4 2019 Portfolio in Review
As of Q4 2019, BlackRock held 5,193 positions worth $2.61T, up 9.5% from $2.38T the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock's Q4 2019 filing shows 167 new, 2,887 increased, 1,450 reduced and 161 closed positions. Its largest new stake was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M. The largest sale was Celgene Corp, an estimated $5.15B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- BlackRock's largest Q4 2019 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M.
- BlackRock added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.71B increase.
- BlackRock's biggest Q4 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $983M.
- BlackRock fully exited Celgene Corp in Q4 2019, selling an estimated $5.15B.
- BlackRock's ten largest holdings make up 15% of its $2.61T portfolio in Q4 2019.
- BlackRock opened 167 new positions and closed 161 in Q4 2019.
- BlackRock's portfolio value rose 9.5% quarter-over-quarter to $2.61T.
Based on BlackRock's 13F filing for Q4 2019, filed 13 Feb 2020.